Rupture of a thoracic aortic aneurysm: A rare adverse reaction following systemic tissue plasminogen activator infusion

Heart and Vessels

Volumn 19, Issue 4, 2004, Pages 208-211

  Hayashi, Hiromitsu ^a   Kawamata, Hiroshi ^a   Ichikawa, Kazuo ^a   Tajima, Hiroyuki ^a   Kumazaki, Tatsuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Aortic aneurysm; Graft and prostheses; Ruptured aorta; Thrombolysis; Tissue plasminogen activator

Indexed keywords

NATEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE PANCREATITIS; AGED; ANEMIA; ANEURYSM RUPTURE; ANEURYSM SURGERY; ANGINA PECTORIS; APHASIA; ARTICLE; BLOOD VESSEL GRAFT; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DYSPNEA; FOLLOW UP; HEMIPLEGIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LIVER DYSFUNCTION; MALE; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; STENT; THORACIC AORTA ANEURYSM; THORACOTOMY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 4344564147     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0746-4     Document Type: Article

References (11)

1. Guerci AG, Gerstenblith G, Brinker JA, Candra NC, Gottlieb SO, Bahr RD, Weiss JL, Shapiro EP, Flaherty JT, Bush DE, Chew PH, Gottlieb SH, Halperin HR, Ouyang P, Walford GD, Bell WR, Fatterpaker AK, Liewellyn M, Topol EJ, Healy B, Siu CO, Becker LC, Weisfeld ML (1987) A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization of elective coronary angioplasty. N Engl J Med 317:1613-1618
2. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR (1988) Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: ASSET. Lancet 2:525-530
3. Goldhaher SZ, Kessler CM. Heit J, Markis J, Sharma GVRK, Dawley D, Nagel JS, Meyerovitz M, Kim D, Vanghan DE, Parker JA, Tumeh SS, Drum D, Loscalzo J, Reagan K, Selwyn AP, Anderson J, Braunwald E (1988) Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 2:293-298
4. The National Institute of Neurological Disorder and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute stroke. N Engl J Med 333:1581-1587
5. Kato K, Kawai C, Hosoda S, Kanazawa T, Hiramori K, Kimata S, Aizawa T, Kajiwara N, Kanmatsuse K, Takano T, Tanaka K, Sugimoto T, Aoki N, Mizuno Y, Matsuda T, Yui Y, Kodama K, Nakamura M (1994) Evaluation of clinical usefulness of MMR701 (Nateplase: rt-PA) in acute myocardial infarction - Phase III study vs urokinase (abstract in English). J Clin Ther Med 10:633-668
6. ACTIVASE (1997) In: Physicians' desk reference, 51st edn. Medical Economics. NJ, pp 1045-1049
7. Tiefnenbrunn AJ (1996) Tissue-type plasminogen activator. In: Messerli FH (ed) Cardiovascular drug therapy 2nd edn. Saunders, Philadelphia, pp 1567-1577
8. Reilly JM (1996) Plasminogen activators in abdominal aortic aneurismal disease. Ann NY Acad Sci 800:151-156
9. Parodi JC, Palmaz JC, Borone HD (1991) Transfermoral intraluminal graft implantation for abdominal aortic aneurysm. Ann Vasc Surg 5:491-499
10. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP (1994) Transluminal placement of endovascular stent-graft for the treatment of decending thoracic aortic aneurysm. N Engl J Med 331:1729-1734
11. Semba CP, Kato N, Kee ST, Lee ST, Mitchell RS, Miller DC, Dake MD (1997) Acute rupture of the descending thoracic aorta: repair with use of endovascular stent-graft. J Vasc Intervent Radiol 8:337-342